Mene Health Group Targets Life Sciences Start-ups to Invest

UTRECHT, Netherlands, Feb. 9, 2019 /PRNewswire-PRWeb/ -- After creating a reputable value chain in clinical research related services Mene Health Group is willing to share its over two decades know-how on new product development and clinical research in life sciences with innovative startups.

Mene Ventures shall provide not only the financial but also hands-on technical support for start-up companies to improving their standing including but not limited to developing their product candidates' regulatory pathway and plan business development activities which they sorely need.

Şule Mene, CEO of Mene Health Group, said this new initiative will empower innovative start-ups lacking the expertise to be prepared for scaling up their business in life sciences.

"The idea is simple though groundbreaking : We have significant experience in life sciences product candidates and we will share this experience with selected startups and also put some capital. We will mentor them, monitor their progress and once they are ready will introduce to our network of investors," she continued.

About Mene Health Group :
Mene Health Group (MHG) is an integrated solution provider to research driven biotechnology, pharmaceutical, medical device industries, universities and authorities since 2002 having different well established brands such as the flagship brand Mene Research ( Turkey's first accredited contract research organization) , Depot Meridian (Turkey's first clinical trial specific warehouse), Mene SMO (Comparator and Conmed Sourcing) and CSL Meridian (temperature sensitive logistics services) and international partnerships with Chrondel S.A. ( Global Site Management Organization).

Mene Health Group is a founding member of Across Global Alliance, offering services in 95 countries with 12 members making the global clinical studies seamless.

For more information , http://www.menehealthgroup.com\

SOURCE Mene Health Group